Unibest
← Back to patent-cliff list

CAS 109-77-3

1,1-Dicyanomethanemalononitrile

Codes: (II)461018-3-a, (IV)461018-4-a, (II)461018-22-a, (VII)461018-25-a, (I)461018-27-a, PEME-022, LEVOS-003

Application context (from source-drug indications)

Waldenström macroglobulinaemiaIbrutinibChronic lymphocytic leukaemiaIbrutinibMantle cell lymphomaIbrutinibGraft-versus-host diseaseIbrutinibNon-small cell lung cancerPemetrexed Disodium Hydrate间皮组织肿瘤Pemetrexed Disodium Hydrate胸膜孤立性纤维瘤Pemetrexed Disodium HydrateBladder cancerPemetrexed Disodium HydrateUrothelial carcinomaPemetrexed Disodium HydrateSolid tumourPemetrexed Disodium HydrateHeart failureLevosimendanPulmonary arterial hypertensionLevosimendan心肌炎LevosimendanPulmonary hypertensionLevosimendanLeft ventricular dysfunctionLevosimendanSubarachnoid haemorrhageLevosimendan

Source drugs (routes using this intermediate)

DrugTierExpiry
IbrutinibTier A — Act now2027
Pemetrexed Disodium HydrateTier B — Position early-
LevosimendanTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Qualified Partner — East China API Works6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.